The treatment of pyogenic skin infections with topical neomycin. 1952

L W KIMBERLY

UI MeSH Term Description Entries
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D011711 Pyoderma Any purulent skin disease (Dorland, 27th ed). Pyodermas
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

L W KIMBERLY
January 1953, Acta dermato-venereologica,
L W KIMBERLY
December 1964, IMJ. Illinois medical journal,
L W KIMBERLY
March 1954, A.M.A. archives of dermatology and syphilology,
L W KIMBERLY
February 1952, Journal of the American Medical Association,
L W KIMBERLY
February 1954, British medical journal,
L W KIMBERLY
May 1951, Canadian Medical Association journal,
L W KIMBERLY
June 1951, Treatment services bulletin. Canada. Department of Veterans' Affairs,
Copied contents to your clipboard!